Updated September 2026Division dressed as a priceboostAGErx review
Ninety-five dollars is a year's total divided by twelve. No invoice ever reads that figure.
The verdict
boostAGErx leads with from $95 monthly, read August 2026, which is what a year bought outright works out to per month. Anyone paying as they go is billed $225 per 28-day cycle, landing at $244 against the calendar.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $244/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Two injected products sold either as a year handed over at once or in 28-day cycles at a considerably higher rate.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages sell plans; nothing describes the clinical side.
Dividing a lump sum by twelve produces a number, not a price. Nobody is ever billed $95, and the arithmetic behind it is not on the page.
What happens when the dose goes up?
The seller writes that the real price varies by product and plan. That admits the figure moves and stops short of saying where.
What the price includes
Buying a year outright works out at $95 monthly on semaglutide and $145 on tirzepatide. Going cycle by cycle costs $225 and $265 every 28 days, landing thirteen times annually. Against the calendar that is $244 and $287. Roughly $1,800 separates the two routes over a year.
What it claims, and what it cites
Compounded to order rather than manufactured. Nobody at the FDA inspects the finished vial before it ships.
Where it holds up, and where it does not
- Strength: Both routes appear on the page
- Strength: Buying outright genuinely saves a lot
- Strength: Each drug carries a figure
- Limitation: The lead figure is arithmetic, not a bill
- Limitation: 28-day cycles land thirteen times annually
- Limitation: A whole year is handed over before dose one
- Limitation: Nothing addresses getting money back
What the evidence says about this kind of treatment
The assessment above is about boostAGErx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader sure of the drug who can hand over a year at once.
- Wrong for
- A reader who takes $95 for what a month costs.
How boostAGErx compares
| Seller | Who it suits | Go |
|---|---|---|
 Bodybuilding Health+ | Readers who want to start without committing a year of money | See Bodybuilding Health+ → |
 bmiMD | Readers who want a microdose and understand that is what the low figure buys | See bmiMD → |
| Blue Haven RX | Readers who read the term definition rather than the word beside the price | See Blue Haven RX → |
More GLP-1 telehealth sellers reviews: Sprout HealthStackMDSumbare WellnessSunlightSuperior RemediesSurpassMD
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Does anyone pay $95 in a month?
- No. It is a year's total divided by twelve.
- What does going cycle by cycle cost?
- $244 against the calendar on semaglutide, $287 on tirzepatide.
- Can money be recovered?
- The pages do not address it.
- Is boostAGErx expensive compared with other GLP-1 telehealth sellers?
- boostAGErx publishes a starting figure of $244/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts boostAGErx above the median. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.